Cognitive Measures, Driving Safety, and Alzheimer's Disease

Author： Bieliauskas Linas A. Roper Brad R. Trobe Jonathan Lacy Maureen

ISSN： 1385-4046

Source： The Clinical Neuropsychologist (Neuropsychology, Development and Cognition: Sec, Vol.12, Iss.2, 1998-05, pp. : 206-212

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Automated neuropsychological assessment metrics (ANAM) measures of cognitive effects of Alzheimer's disease

By Levinson D.

Archives of Clinical Neuropsychology, Vol. 20, Iss. 3, 2005-05 ,pp. : 403-408

Oxford University Press

Access to resources Recommend Favorite

Volumetric MRI and cognitive measures in Alzheimer disease: Comparison of markers of progression

By Ridha B.

Journal of Neurology, Vol. 255, Iss. 4, 2008-04 ,pp. : 567-574

Springer Publishing Company

Access to resources Recommend Favorite

Automated MRI measures identify individuals with mild cognitive impairment and Alzheimer's disease

By Desikan Rahul S.

Brain, Vol. 132, Iss. 8, 2009-08 ,pp. : 2048-2057

Oxford University Press

Access to resources Recommend Favorite

Do Primary and Supplementary Measures of Semantic Memory Predict Cognitive Decline by Patients With Alzheimer's Disease?

By Beatty William W. Salmon David P. Tröster Alexander I. Tivis Rick D.

Aging, Neuropsychology, and Cognition (Neuropsychology, Development and Cogniti, Vol. 9, Iss. 1, 2002-03 ,pp. : 1-10

Routledge Ltd

Access to resources Recommend Favorite

The Safety, Tolerability, Pharmacokinetics and Cognitive Effects of GSK239512, a Selective Histamine H3 Receptor Antagonist in Patients with Mild to Moderate Alzheimer's Disease: A Preliminary Investigation

Current Alzheimer Research, Vol. 10, Iss. 3, 2013-03 ,pp. : 240-251

Bentham Science Publishers

Access to resources Recommend Favorite